# HMS Ophthalmology OPD Phase 9 Verification

**Date:** 15 October 2026  
**Phase:** 9 - Clinical review completion amendment and summary  
**Status:** COMPLETE

## Implemented functionality

- Added exact task/result/clinical-version doctor review with reviewer, time, comment, transition history, optimistic concurrency, and audit.
- Added branch/visit-subtype completion-profile resolution and structured readiness output for the approved requirement-code set.
- Added same-consultation test-task/shared-order deferral with reason, plan or future due date, and responsible active doctor.
- Added authorized completion override only when enabled by configuration and only for the exact current unmet-code snapshot.
- Added one versioned finalization head per visit with append-only deferrals, overrides, completion approvals, and amendment episodes.
- Added authenticated doctor approval and idempotent initial completion across Ophthalmology context/review/finalization and authoritative OPD consultation/visit/appointment, Patient timeline, and audit.
- Locked normal context, alert, task, result, clinical-review, and optical-prescription writes after finalization.
- Added reasoned reopening, append-only before/after amendments, doctor reapproval, superseding clinical versions, and scoped summary/history reads.

## Existing functionality reused

- Reused the Phase 1 OPD consultation, visit, appointment, Patient timeline, audit, expected-version, and required-transaction foundations.
- Reused Phases 2-8 Ophthalmology context, configuration, intake, alert, task/result, doctor validation, clinical-review, optical-prescription, and consolidated doctor-review contracts.
- Reused the existing permission inventory: Test Review `Review` and Consultation `Complete`, `Override`, `Reopen`, and `Amend`.
- Shared medication, investigation order, procedure, referral, follow-up, Patient, Doctor, Appointment, and OPD records remain authoritative; no duplicate subsystem was introduced.

## Files and modules changed including shared files

- Ophthalmology: new `ophthalmology-consultation.model.ts`; extended task/review models, types, schemas, repository, service, routes, and `ophthalmology.phase9.test.ts`.
- Shared construction: `apps/api/src/shared/services/service-registry.ts` now injects existing OPD Consultation, Appointment, and Patient repositories into the Ophthalmology service.
- Phase 8 clinical-review follow-up decision/status and test-task review metadata were minimally extended for Phase 9 completion and review.
- Documentation: Developer A prompt, Phase 0 alignment matrix, API contract v1.8.0, Phase 9 gap note, and this verification.
- No frontend, permission seed, generated artifact, or `scope/HMS Local` file was changed for Phase 9.

## Backend validation transaction permission scope audit and error handling

- Completion requires exactly one active branch `COMPLETION_PROFILE` matching the visit subtype and bound to the context. Unsupported/missing structural requirements return `OPHTHALMOLOGY_CONFIGURATION_REQUIRED`; no clinical defaults are inferred.
- Every mutating endpoint uses existing permission middleware plus branch/department/resource scope, active-doctor validation where required, expected state/version conditions, and explicit conflict/error codes.
- Result review binds the exact completed result clinical version. Deferrals validate same encounter/patient/branch resources and an active responsible doctor. Overrides require `allow_override: true`, a reason, and the exact current unmet set.
- Initial completion uses one MongoDB transaction for specialty and shared OPD state, linked appointment, timeline, and audit. Idempotency key/fingerprint replay is safe; mismatched reuse is rejected.
- Finalization has a unique visit index plus patient/branch/status and completion-key indexes. Conditional updates reject stale/concurrent completion, reopen, amendment, and reapproval attempts.
- Approval and lifecycle audits retain actor, doctor/resource IDs, versions, reasons, status, and timestamps. Amendment values are preserved in the controlled finalization history while audit metadata stores hashes rather than full clinical content.

## HMS Local UI patterns reused

- Reviewed the HMS Local patient header, tabbed clinical workspace, sticky summary, explicit completion confirmation, return-to-queue flow, and status presentation as interaction guidance only.
- Phase 9 is backend-owned; no React screen or prototype file was modified and no mock/local-storage behavior was promoted to production.

## Automated checks and manual tests completed

- Focused Phases 6-9 plus legacy OPD diagnosis regression: **5 files, 62 tests passed**.
- Focused Phase 9: **1 file, 7 tests passed** covering exact-version review/stale retry, structured incomplete readiness, ambiguous configuration rejection, exact override, success, duplicate idempotent replay, mismatched replay, concurrency, unauthorized doctor, transaction rollback, final-write locking, reopen, append-only amendment, reapproval, timeline, and audit.
- API typecheck and build: **passed**. Web typecheck and production build: **passed**.
- Phase-owned API lint: **passed**.
- Full API regression: **104 files and 1015 tests passed; 1 unrelated pre-existing test failed**. `test/department-module-visibility.test.ts` expects `context.departments`, but the received value is `undefined`; no Phase 9 file participates in that assertion.
- Full API lint remains blocked by **51 unrelated pre-existing errors** in Insurance, Patient, and patient-document storage files. Full web lint remains blocked by **6 unrelated pre-existing errors** in doctor-signature/patient/media components. The Phase 9 file set is lint-clean.
- Live transaction-capable MongoDB integration tests validate persistence, concurrency, rollback, authorization, and idempotent retry. Browser workflow testing is not applicable because Phase 9 contains no frontend implementation.

## Remaining dependency or clarification for Phase 10

- Hospital production completion requirements and mandatory-test lists remain DEC-06 configuration data; Phase 9 intentionally seeds no clinical assumptions.
- `doc/HMS_Release2_FSD.docx` remains absent. The approved Ophthalmology FSD and DEC-01 through DEC-12 remain authoritative for this specialty scope.
- Portal publication/withdrawal/republishing, external result adapters, document binary policy, downstream billing/pharmacy/procedure dispatch, reports, dashboards, and external compensation remain Phase 10.
- Digital approval is an authenticated approval event, not a cryptographic-signature compliance claim.

## Next-phase stop confirmation

Phase 9 is complete within the approved backend boundary. Phase 10 subsequently completed on 16 October 2026; Phase 11 has not started.
